• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
1AD

ADALTA LIMITED

25.0% ! 0.3¢
Market Cap $2.782M  !

AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company... AdAlta Limited is an Australia-based clinical-stage biotechnology company. The Company uses its i-body platform to discover and develop protein therapeutics addressing drug targets that are challenging for other technologies. The Company's first-in-class lead asset, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, for which current therapies are sub-optimal. AD-214 is an Fc-Fusion protein that contains two AD-114 i-body molecules at the front end, that bind with high affinity to the human target, CXCR4. It is also engaged in developing i-body enabled Chimeric antigen receptor T cell (CAR-T) cells. It co-develops i-bodies as diagnostic imaging agents (i-PET imaging) against Granzyme B, a biomarker of response to immuno-oncology drugs.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
1AD 30/07/25 0 184
30/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  184 
1AD 28/07/25 0 172
28/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  172 
1AD 23/07/25 0 259
23/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  259 
1AD 11/07/25 0 231
11/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  231 
1AD 11/07/25 0 211
11/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  211 
1AD 02/07/25 0 264
02/07/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  264 
1AD 30/06/25 0 390
30/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  390 
1AD 13/06/25 0 289
13/06/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  289 

See All Discussions arrow Created with Sketch.

Timeline

1AD Investor Presentation
30 Jul 09:45
 
Notification of cessation of securities - 1AD
28 Jul 16:17
 
Quarterly Appendix 4C and Activities Report
23 Jul 08:49
 
Cleansing Notice
11 Jul 08:59
 
Application for quotation of securities - 1AD
11 Jul 08:56
 
Final Director's Interest Notice
02 Jul 15:19
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
0.3¢
Change
0.001(25.0%)
Mkt cap ! $2.782M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $190 75.96K

Buyers (Bids)

No. Vol. Price($)
9 6258466 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 15952546 18
View Market Depth
Last trade - 15.12pm 31/07/2025 (20 minute delay) ?
Last
0.2¢
  Change
0.001 ( 20.0 %)
Open High Low Volume
0.2¢ 0.2¢ 0.2¢ 16000
Last updated 11.13am 31/07/2025 ?
1AD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.